Granted Patent
B2
US 9,200,310 · App. 14/137,608 · Granted Dec 1, 2015
High fidelity restriction endonucleases
Inventors:
Zhenyu Zhu (Beverly, MA); Aine Quimby (Newton, NH); Shengxi Guan (Stoneham, MA); Dapeng Sun (Arlington, MA); Yishu Huang (Shanghai, CN); Xuhui Lai (Shanghai, CN); Siu-hong Chan (Ipswich, MA); Xianghui Li (Shanghai, CN); Shuang-Yong Xu (Lexington, MA); Chunhua Zhang (Zhenjiang, CN)
Assignee:
New England Biolabs, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Methods and compositions are provided for engineering mutant enzymes with reduced star activity where the mutant enzymes have a fidelity index (FI) in a specified buffer that is greater than the FI of the non-mutated enzyme in the same buffer.
Claims (2)
1. A composition comprising a variant MluI restriction endonuclease having reduced star activity, wherein the variant MluI restriction endonuclease comprises an amino acid sequence that differs from the amino acid sequence of the parent MluI restriction endonuclease by two amino acid substitutions at positions corresponding to positions 112 and 132 of SEQ ID NO:28.
2. A composition according to claim 1 , wherein the amino acid substitutions are E112A and R132A.
Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS
Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 2, 2015
From: ZHU, ZHENYU; QUIMBY, AINE; GUAN, SHENGXI; SUN, DAPENG; HUANG, YISHU; LAI, XUHUI; CHAN, SIU-HONG; LI, XIANGHUI; XU, SHUANG-YONG; ZHANG, CHUNHUA
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 035067/0976 →
Continuity (6)
Provisional Application
60959203
· Jul 12, 2007
Provisional Application
61387800
· Sep 29, 2010
Provisional Application
61301666
· Feb 5, 2010